Regulation of the wild-type and Y1235D mutant Met kinase activation.

Regulation of the wild-type and Y1235D mutant Met kinase activation.

Met receptor tyrosine kinase plays a crucial role in the regulation of a large number of cellular processes and, when deregulated by overexpression or mutations, leads to tumor growth and invasion. The Y1235D mutation identified in metastases was shown to induce constitutive activation and a motile-...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Cristiani, C, Rusconi, L, Perego, R, Schiering, N, Kalisz, H, Knapp, S, Isacchi, A
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2005

Eitemau Tebyg

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
gan: Schiering, N, et al.
Cyhoeddwyd: (2003)

Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer
gan: Ling Lim, et al.
Cyhoeddwyd: (2019-01-01)

Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.
gan: Daniele Rapino, et al.
Cyhoeddwyd: (2015-01-01)

Kurultai of 1235: Question of Expansion of the Ulus of Jochi »
gan: I.М. Mirgaleev
Cyhoeddwyd: (2014-09-01)

Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding.
gan: Visco, C, et al.
Cyhoeddwyd: (2000)

P1235: INVESTIGATION OF THE CO-MUTATIONAL LANDSCAPE OF ALK-POSITIVE ALCL
gan: Matteo Villa, et al.
Cyhoeddwyd: (2023-08-01)

Early Hungarian Information about the Mongol Western Campaign (1235–1242) »
gan: Roman Hautala
Cyhoeddwyd: (2015-09-01)

1,2,3,5-Tetrahydronaphtho[2,1-c]oxepine
gan: Alan J. Lough, et al.
Cyhoeddwyd: (2020-03-01)

Preparation of 4-benzylsulfanyl[1,2,3,5]dithiadiazol-1-ylium chlorides: potential precursors to meso-ionic 1,2,3,5-dithiadiazolium-4-thiolate
gan: Thomas Gelbrich, et al.
Cyhoeddwyd: (2002-10-01)

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia
gan: Burcu Aslan, et al.
Cyhoeddwyd: (2022-05-01)

1235 Safety of Immune checkpoint inhibitors in elderly patients over 75 years
gan: Muhammad Awidi, et al.
Cyhoeddwyd: (2023-11-01)

Tau decay into $$\nu _\tau $$ ντ and $$a_1(1260)$$ a1(1260) , $$b_1(1235)$$ b1(1235) , and two $$K_1(1270)$$ K1(1270)
gan: L. R. Dai, et al.
Cyhoeddwyd: (2020-07-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
gan: Zhe Zhang, et al.
Cyhoeddwyd: (2019-11-01)

Proteome Regulation Patterns Determine Escherichia coli Wild-Type and Mutant Phenotypes
gan: Tobias B. Alter, et al.
Cyhoeddwyd: (2021-04-01)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
gan: Jianqun Kou, et al.
Cyhoeddwyd: (2018-09-01)

1,2,3,5-Tetramethyl-1H-pyrazol-2-ium triiodide
gan: Stefan Oberparleiter, et al.
Cyhoeddwyd: (2016-08-01)

Observing student´s syntactic errors and the perceptions towards writing in the composition course LM-1235
gan: César Alberto Navas Brenes
Cyhoeddwyd: (2017-04-01)

History from Comic Hypotheses: Stratocles, Lachares, and <i>P.Oxy. 1235</i>
gan: Lara O'Sullivan
Cyhoeddwyd: (2010-11-01)

In silico analysis of wild-type and mutant KRAS
gan: Frengki Frengki, et al.
Cyhoeddwyd: (2019-05-01)

Raoul de Houdenc et les routes noveles de la fiction 1200-1235
gan: Fernando Carmona Fernández
Cyhoeddwyd: (2019-12-01)

Protein tyrosine phosphatase receptor type E (PTPRE) regulates the activation of wild-type KIT and KIT mutants differently
gan: Shaoting Zhang, et al.
Cyhoeddwyd: (2021-07-01)

Aurora kinase-C-T191D is constitutively active mutant
gan: Khan Jabbar, et al.
Cyhoeddwyd: (2012-03-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
gan: Wenshu Li, et al.
Cyhoeddwyd: (2024-07-01)

Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
gan: Elena Butturini, et al.
Cyhoeddwyd: (2021-11-01)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
gan: Figeys Daniel, et al.
Cyhoeddwyd: (2008-09-01)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
gan: Chao Sun, et al.
Cyhoeddwyd: (2020-04-01)

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase
gan: Burcu Aslan, et al.
Cyhoeddwyd: (2021-09-01)

Glucose Starvation Alters Heat Shock Response, Leading to Death of Wild Type Cells and Survival of MAP Kinase Signaling Mutant.
gan: Nora Plesofsky, et al.
Cyhoeddwyd: (2016-01-01)

Transformation of HepG2 nascent lipoproteins by LCAT: modulation by HepG2 d > 1.235 g/ml fraction.
gan: MR McCall, et al.
Cyhoeddwyd: (1993-01-01)

In silico analysis of the wild-type and mutant-type of BRCA2 gene
gan: Jingjing Li, et al.
Cyhoeddwyd: (2024-05-01)

The 4-(3-chloro-4-methylphenyl)-1,2,3,5-dithiadiazol-3-yl radical
gan: Jacqueline M. Cole, et al.
Cyhoeddwyd: (2011-09-01)

Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
gan: Dai Yao, et al.
Cyhoeddwyd: (2012-05-01)

Metabolomics of 293T IDH1 mutant and wild-type cells
gan: Walsby-Tickle, J
Cyhoeddwyd: (2020)

Normalization of NPM1 mutant transcript to the wild‐type transcript
gan: Lawrence J. Jennings
Cyhoeddwyd: (2022-11-01)

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
gan: YiQing Lü, et al.
Cyhoeddwyd: (2024-04-01)

Retraction: Aurora kinase-C-T191D is constitutively active mutant
gan: Khan Jabbar, et al.
Cyhoeddwyd: (2012-06-01)

Antitumor imidazotetrazines. 38. New 8-substituted derivatives of the imidazo[5,1-d]-1,2,3,5-tetrazines temozolomide and mitozolomide
gan: David A. F. Langnel, et al.
Cyhoeddwyd: (2000-08-01)

N-Benzyl-6-deoxy-3,6-iminomethylene-1,2,3,5-O-tetraacetyl-&#945;-d-1(S)-epiallofuranose
gan: Qiurong Zhang, et al.
Cyhoeddwyd: (2011-06-01)

In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells
gan: Ji Yeon Song, et al.
Cyhoeddwyd: (2024-11-01)

Molecular Dynamics and Optimization Studies of Horse Prion Protein Wild Type and Its S167D Mutant
gan: Jiapu Zhang
Cyhoeddwyd: (2024-08-01)